Microchip Technology Incorporated (LON:0K19)
London flag London · Delayed Price · Currency is GBP · Price in USD
65.60
-1.40 (-2.08%)
At close: Aug 1, 2025

Verve Therapeutics Revenue

In the fiscal year ending March 31, 2025, Microchip Technology had annual revenue of $4.40B USD, down -42.35%. Microchip Technology had revenue of $970.50M in the quarter ending March 31, 2025, a decrease of -26.80%.

Revenue
$4.40B
Revenue Growth
-42.35%
P/S Ratio
7.93
Revenue / Employee
$226.89K
Employees
19,400
Market Cap
27.03B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20254.40B-3.23B-42.35%
Mar 31, 20247.63B-804.30M-9.53%
Mar 31, 20238.44B1.62B23.72%
Mar 31, 20226.82B1.38B25.42%
Mar 31, 20215.44B164.20M3.11%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro